Practical steps to improve chronic hepatitis C treatment in people with opioid use disorder
Roncero, Carlos (Psychiatric Service, University of Salamanca Health Care Complex, Institute of Biomedicine of Salamanca, University of Salamanca)
Ryan, Pablo (Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM))
Littlewood, Richard (applied strategic)
Macías, Juan (Hospital Universitario Virgen de Valme (Sevilla, Andalusia))
Ruiz, Juan (Provincial Center of Drug Addiction)
Seijo, Pedro (Addiction Treatment Center of Villamartín)
Palma-Álvarez, Raúl Felipe (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal)
Vega, Pablo (Institute of Addictions)

Data:	2018
Resum:	People with a history of injecting drugs have high prevalence of hepatitis C virus (HCV) infection, and many have opioid use disorder (OUD). Modern HCV therapies with improved efficacy and tolerability are available, but access is often limited for this group, who may be underserved for health care and face social inequity. This work develops practical steps to improve HCV care in this population. Practical steps to improve HCV care in OUD populations were developed based on clinical experience from Spain, structured assessment of published evidence. Options for improving care at engagement/screening stages include patient education programs, strong provider-patient relationship, peer support, and adoption of rapid effective screening tools. To facilitate work up/treatment, start options include simplified work up process, integration of HCV and OUD care, and continuous psychosocial support prior, during, and after HCV treatment. It is important to plan on local basis to set up a joint integrated approach between specific drug treatment services and local points of HCV care. The elements for a specific integrated program should be chosen from options identified, including education services, peer input, organization to make HCV screening and treatment easier by co-location of services, and wider access to prescribing direct-acting antiviral (DAA) therapy.
Drets:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original.
Llengua:	Anglès
Document:	Article ; recerca ; Versió publicada
Matèria:	HCV ; Opioid use disorder ; Treatment ; Elimination ; Practical recommendations
Publicat a:	Hepatic Medicine : Evidence and Research, Vol. 11 (december 2018) , p. 1-11, ISSN 1179-1535

DOI: 10.2147/HMER.S187133
PMID: 30613166

11 p, 319.6 KB

El registre apareix a les col·leccions:
Articles > Articles de recerca
Articles > Articles publicats